Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
autoimmune disease
Biotech
Boehringer's deal frenzy continues with $570M autoimmune pact
The German pharma is turning to established partner CDR-Life for a new trispecific autoimmune antibody.
Darren Incorvaia
Nov 4, 2025 8:00am
Novartis’ phase 3 wins in Sjögren's see high placebo effect
Oct 29, 2025 12:03pm
Kyverna links CAR-T to autoimmune improvements in small trial
Oct 29, 2025 10:00am
Nobel winner turns rogue T cells into their own treatment
Oct 23, 2025 10:35am
British biotech elevates with $70M and midstage arthritis asset
Oct 21, 2025 7:01pm
How Nobel-winning cells could become a 'universal drug'
Oct 21, 2025 2:00pm